Bristol-Myers Squibb Company
BMY
$56.45
$0.781.40%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 48.48B | 48.19B | 48.03B | 47.70B | 47.64B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.48B | 48.19B | 48.03B | 47.70B | 47.64B |
| Cost of Revenue | 13.58B | 13.19B | 12.90B | 12.44B | 12.06B |
| Gross Profit | 34.90B | 35.00B | 35.14B | 35.26B | 35.58B |
| SG&A Expenses | 7.17B | 7.15B | 6.91B | 7.20B | 7.43B |
| Depreciation & Amortization | 2.92B | 3.32B | 4.18B | 5.76B | 7.35B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.18B | 33.15B | 33.71B | 35.04B | 36.51B |
| Operating Income | 15.31B | 15.05B | 14.32B | 12.66B | 11.13B |
| Income Before Tax | 9.60B | 9.33B | 8.03B | 6.59B | 6.11B |
| Income Tax Expenses | 2.32B | 2.27B | 1.99B | 1.53B | 671.00M |
| Earnings from Continuing Operations | 7.27K | 7.06K | 6.05K | 5.07K | 5.44K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.00M | -1.00M | -6.00M | -16.00M | -18.00M |
| Net Income | 7.28B | 7.05B | 6.04B | 5.05B | 5.42B |
| EBIT | 15.31B | 15.05B | 14.32B | 12.66B | 11.13B |
| EBITDA | 18.98B | 19.12B | 19.23B | 19.16B | 19.22B |
| EPS Basic | 3.57 | 3.47 | 2.97 | 2.49 | 2.67 |
| Normalized Basic EPS | 4.85 | 4.87 | 4.43 | 3.92 | 3.44 |
| EPS Diluted | 3.56 | 3.45 | 2.96 | 2.47 | 2.66 |
| Normalized Diluted EPS | 4.84 | 4.86 | 4.42 | 3.91 | 3.43 |
| Average Basic Shares Outstanding | 8.15B | 8.14B | 8.13B | 8.12B | 8.12B |
| Average Diluted Shares Outstanding | 8.17B | 8.16B | 8.15B | 8.15B | 8.14B |
| Dividend Per Share | 2.50 | 2.49 | 2.48 | 2.46 | 2.44 |
| Payout Ratio | 69.69% | 71.52% | 82.81% | 98.12% | 90.59% |